Mutational analysis of PDGFR–RAS/MAPK pathway activation in childhood medulloblastoma
Open Access
- 31 March 2006
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 42 (5), 646-649
- https://doi.org/10.1016/j.ejca.2005.11.023
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Medulloblastoma: signalling a change in treatmentThe Lancet Oncology, 2004
- PDGFRB is overexpressed in metastatic medulloblastomaNature Genetics, 2003
- PDGF receptors as cancer drug targetsCancer Cell, 2003
- Issues and progress with protein kinase inhibitors for cancer treatmentNature Reviews Drug Discovery, 2003
- What's new in neuro-oncology? Recent advances in medulloblastomaEuropean Journal of Paediatric Neurology, 2003
- PDGFRA Activating Mutations in Gastrointestinal Stromal TumorsScience, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinibHematology/Oncology Clinics of North America, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic diseaseNature Genetics, 2001